FI934710A - 4-Aryl-3- (HETEROARYLUREIDO) KINOLINDERIVAT - Google Patents

4-Aryl-3- (HETEROARYLUREIDO) KINOLINDERIVAT Download PDF

Info

Publication number
FI934710A
FI934710A FI934710A FI934710A FI934710A FI 934710 A FI934710 A FI 934710A FI 934710 A FI934710 A FI 934710A FI 934710 A FI934710 A FI 934710A FI 934710 A FI934710 A FI 934710A
Authority
FI
Finland
Prior art keywords
kinolinderivat
heteroarylureido
aryl
Prior art date
Application number
FI934710A
Other languages
Finnish (fi)
Other versions
FI934710A0 (en
Inventor
Ernest S Hamanaka
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI934710A0 publication Critical patent/FI934710A0/en
Publication of FI934710A publication Critical patent/FI934710A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
FI934710A 1991-04-26 1993-10-25 4-Aryl-3- (HETEROARYLUREIDO) KINOLINDERIVAT FI934710A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69232391A 1991-04-26 1991-04-26
PCT/US1992/001801 WO1992019614A1 (en) 1991-04-26 1992-03-16 4-aryl-3-(heteroarylureido)quinoline derivatives

Publications (2)

Publication Number Publication Date
FI934710A0 FI934710A0 (en) 1993-10-25
FI934710A true FI934710A (en) 1993-10-25

Family

ID=24780107

Family Applications (1)

Application Number Title Priority Date Filing Date
FI934710A FI934710A (en) 1991-04-26 1993-10-25 4-Aryl-3- (HETEROARYLUREIDO) KINOLINDERIVAT

Country Status (20)

Country Link
EP (1) EP0590094A1 (en)
JP (1) JPH0776215B2 (en)
CN (1) CN1066068A (en)
AU (1) AU1879792A (en)
BR (1) BR9205939A (en)
CA (1) CA2108014A1 (en)
CZ (1) CZ395592A3 (en)
DE (1) DE9290049U1 (en)
FI (1) FI934710A (en)
HU (1) HUT65748A (en)
IE (1) IE921330A1 (en)
IL (1) IL101627A0 (en)
MX (1) MX9201916A (en)
NO (1) NO933837L (en)
NZ (1) NZ242493A (en)
PT (1) PT100426A (en)
TW (1) TW197436B (en)
WO (1) WO1992019614A1 (en)
YU (1) YU44592A (en)
ZA (1) ZA922976B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE175196T1 (en) * 1992-01-23 1999-01-15 Pfizer 4-PHENYL-3-(HETEROARYLUREIDO)-1,2-DIHYDRO-2-OXOCINOLINE DERIVATIVES, AS ANTIHYPERCHOLESTEROLEMIC AND ANTIATHEROSCLEROTIC AGENTS
US5565472A (en) * 1992-12-21 1996-10-15 Pfizer Inc. 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxo-quinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents
NZ264063A (en) * 1993-08-13 1995-11-27 Nihon Nohyaku Co Ltd N-(2-phenylpyrid-3-yl)- and n-(4-phenylpyrimidin-5-yl)-n'-phenylurea derivatives and pharmaceutical compositions
US5843957A (en) * 1995-05-19 1998-12-01 Sumitomo Pharmaceuticals Company, Ltd. Naphthyridine derivatives
CA2222687A1 (en) * 1995-05-31 1996-12-05 Masami Muraoka Novel naphthyridine derivatives
CA2272068A1 (en) * 1996-11-26 1998-06-04 Masami Muraoka Novel naphthyridine derivatives
WO1999043659A1 (en) 1998-02-25 1999-09-02 Sumitomo Pharmaceuticals Co., Ltd. Pyridone derivatives and process for producing the same
US6452008B2 (en) 1998-02-25 2002-09-17 Sumitomo Pharmaceuticals Company, Limited Pyridone derivatives and process for preparing the same
WO2005058834A2 (en) * 2003-12-12 2005-06-30 Wyeth Quinolines useful in treating cardiovascular disease
CN103601677B (en) * 2013-11-19 2015-11-18 清华大学 Prepare the method for 2-alkylthio quinoline

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE892088L (en) * 1988-07-12 1990-01-12 William Henry Deryk Morris Quinoline derivatives, their production and use
WO1991004027A1 (en) * 1989-09-15 1991-04-04 Pfizer Inc. New n-aryl and n-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme a: cholesterol acyl transferase (acat)
TW205037B (en) * 1989-10-06 1993-05-01 Takeda Pharm Industry Co Ltd

Also Published As

Publication number Publication date
NO933837L (en) 1993-10-25
FI934710A0 (en) 1993-10-25
BR9205939A (en) 1994-09-27
JPH06501025A (en) 1994-01-27
HU9303025D0 (en) 1994-01-28
AU1879792A (en) 1992-12-21
HUT65748A (en) 1994-07-28
TW197436B (en) 1993-01-01
ZA922976B (en) 1993-10-25
WO1992019614A1 (en) 1992-11-12
DE9290049U1 (en) 1994-01-05
MX9201916A (en) 1992-11-01
NZ242493A (en) 1994-08-26
JPH0776215B2 (en) 1995-08-16
CZ395592A3 (en) 1994-02-16
EP0590094A1 (en) 1994-04-06
PT100426A (en) 1993-08-31
CA2108014A1 (en) 1992-10-27
IE921330A1 (en) 1992-11-04
CN1066068A (en) 1992-11-11
IL101627A0 (en) 1992-12-30
YU44592A (en) 1994-12-28

Similar Documents

Publication Publication Date Title
DE59206583D1 (en) WINDSIGHTER
ATE137279T1 (en) HEADCASE
DE59209950D1 (en) Bottle-
ATA131391A (en) REIBRING
BR9204511A (en) COLLECTOR-WINDER
DE59208716D1 (en) LYMPHOIDES CD30-ANTIGEN
FI934710A0 (en) 4-Aryl-3- (HETEROARYLUREIDO) KINOLINDERIVAT
ATA170491A (en) WALLSTONE
ATA39792A (en) MAEHWERK
ATE163916T1 (en) ETHYL-6-FORMYLOXY-4-HEXENOATE
ATA9892A (en) FORMSTEIN
ATA67791A (en) ROLLSKI
BR9201945A (en) FILATORIO
CA68725S (en) FURNITURE-GAME
ATA235591A (en) ELUER
ATA23591A (en) MUENZKASSA
BR9104939A (en) FOOT-TENNIS
BR9104568A (en) DDY-TEST
BR9104416A (en) SUPERCALIBRATION
SE9101390D0 (en) RIBBDAECKSFORM
BR9104152A (en) BOMBIT
BR9104106A (en) TELEOFERTA
BR9103560A (en) GASOTECA
BR9105653A (en) LUDOCHEMICAL
BR9102019A (en) BRAZBLOC